Wed, October 17, 2018
Tue, October 16, 2018
Mon, October 15, 2018

Donald Ellis Maintained (ACRS) at Buy with Decreased Target to $34 on, Oct 16th, 2018

Donald Ellis of JMP Securities, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Buy with Decreased Target from $47 to $34 on, Oct 16th, 2018.

Donald, nor any peers, have made any analyst calls on ACRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30